No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: RBC unregistered to registered account

tada, this is how I understand it.

Zenith Epigenetics Ltd (ZEL) is a subsidiary of Zenith capital Corp. (ZCC)

ZEL owns all of the Intelectual property.

ZCC hold the Royalty Preferred Shares (RPS) of RVX.

Should DM issue an IPO that would be for ZEL

Should ZEL be sold outright all of the cash that it generates will be held by ZCC.

There would be no reason for ZCC to continue doing any sort of business. ZCC will be liquidated and funds distributed to the unitholders. 

 

IMO....Koo

 

 

 

 

Share
New Message
Please login to post a reply